DUBLIN--(BUSINESS WIRE)--The "Global COVID-19 Clinical Trial Pipeline Highlights, 2020" report has been added to ResearchAndMarkets.com's offering.
Global COVID-19 Clinical Trial Pipeline Highlights, 2020 provides the most up-to-date information on key pipeline products in the global COVID-19 market. It covers emerging therapies for COVID-19 in active clinical development stages including early and late-stage clinical trials.
The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages: The report provides COVID-19 pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes: The report provides COVID-19 pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company: The report provides COVID-19 pipeline products by the company.
Short-term Launch Highlights: Find out which COVID-19 pipeline products will be launched in the US and Ex-US till 2025.
Key Topics Covered
1. COVID-19 Pipeline by Stages
2. COVID-19 Phase 3 Clinical Trial Insights
3. COVID-19 Phase 2 Clinical Trial Insights
4. COVID-19 Phase 1 Clinical Trial Insights
5. COVID-19 Preclinical Research Insights
6. COVID-19 Discovery Stage Insights
List of Tables
Table 1: COVID-19 Phase 3 Clinical Trials, 2020
Table 2: COVID-19 Phase 2 Clinical Trials, 2020
Table 3: COVID-19 Phase 1 Clinical Trials, 2020
Table 4: COVID-19 Preclinical Research, 2020
Table 5: COVID-19 Discovery Stage, 2020
List of Figures
Figure 1: COVID-19 Pipeline Molecules by Clinical Trials Stage, 2020
Figure 2: COVID-19 Phase 3 Clinical Trial Highlights, 2020
Figure 3: COVID-19 Phase 2 Clinical Trial Highlights, 2020
Figure 4: COVID-19 Phase 1 Clinical Trial Highlights, 2020
Figure 5: COVID-19 Preclinical Research Highlights, 2020
Figure 6: COVID-19 Discovery Stage Highlights, 2020
For more information about this report visit https://www.researchandmarkets.com/r/3ja312